Search research articles
Contact Us
Filters
Showing results (101-110 of 112) with videos related to
Page
of 12
Sort By:
Neuroscience and Biobehavioral Reviews
|
October 31, 2021
Neuromelanin accumulation in patients with schizophrenia: A systematic review and meta-analysis
Fumihiko Ueno, Yusuke Iwata, Shinichiro Nakajima, et al.
Neuroimage. Clinical
|
October 12, 2021
Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophrenia
Takashi Itahashi, Yoshihiro Noda, Yusuke Iwata, et al.
Journal of Psychopharmacology (Oxford, England)
|
May 2, 2019
Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: A systematic review and meta-analysis
Sakiko Tsugawa, Yoshihiro Noda, Ryosuke Tarumi, et al.
Schizophrenia Research
|
June 23, 2024
Clozapine treatment and astrocyte activity in treatment resistant schizophrenia: A proton magnetic resonance spectroscopy study
Edgardo Torres-Carmona, Shinichiro Nakajima, Yusuke Iwata, et al.
Psychiatry and Clinical Neurosciences
|
September 16, 2022
Gamma-aminobutyric acid (GABA) levels in the midcingulate cortex and clozapine response in patients with treatment-resistant schizophrenia: A proton magnetic resonance spectroscopy (<sup>1</sup> H-MRS) study
Fumihiko Ueno, Shinichiro Nakajima, Yusuke Iwata, et al.
Psychiatry and Clinical Neurosciences
|
September 27, 2022
Decreased cortical gyrification and surface area in the left medial parietal cortex in patients with treatment-resistant and ultratreatment-resistant schizophrenia
Kazutoshi Kitajima, Shunsuke Tamura, Daiki Sasabayashi, et al.
Molecular Psychiatry
|
September 29, 2021
Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of <sup>1</sup>H-magnetic resonance spectroscopy studies
Tomomi Nakahara, Sakiko Tsugawa, Yoshihiro Noda, et al.
Molecular Psychiatry
|
April 21, 2022
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment
Masataka Wada, Yoshihiro Noda, Yusuke Iwata, et al.
Iscience
|
August 5, 2025
ARID1A mutation drives gastric tumorigenesis via activating type 2 immune dominant microenvironment
Junya Arai, Yoku Hayakawa, Nobumi Suzuki, et al.
Schizophrenia Bulletin
|
November 26, 2023
Disease Progression Patterns of Brain Morphology in Schizophrenia: More Progressed Stages in Treatment Resistance
Daichi Sone, Alexandra Young, Shunichiro Shinagawa, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 112) with videos related to
Sort By:
Page
of 12
Neuroscience and Biobehavioral Reviews
|
October 31, 2021
Neuromelanin accumulation in patients with schizophrenia: A systematic review and meta-analysis
Fumihiko Ueno, Yusuke Iwata, Shinichiro Nakajima, et al.
Neuroimage. Clinical
|
October 12, 2021
Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophrenia
Takashi Itahashi, Yoshihiro Noda, Yusuke Iwata, et al.
Journal of Psychopharmacology (Oxford, England)
|
May 2, 2019
Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: A systematic review and meta-analysis
Sakiko Tsugawa, Yoshihiro Noda, Ryosuke Tarumi, et al.
Schizophrenia Research
|
June 23, 2024
Clozapine treatment and astrocyte activity in treatment resistant schizophrenia: A proton magnetic resonance spectroscopy study
Edgardo Torres-Carmona, Shinichiro Nakajima, Yusuke Iwata, et al.
Psychiatry and Clinical Neurosciences
|
September 16, 2022
Gamma-aminobutyric acid (GABA) levels in the midcingulate cortex and clozapine response in patients with treatment-resistant schizophrenia: A proton magnetic resonance spectroscopy (<sup>1</sup> H-MRS) study
Fumihiko Ueno, Shinichiro Nakajima, Yusuke Iwata, et al.
Psychiatry and Clinical Neurosciences
|
September 27, 2022
Decreased cortical gyrification and surface area in the left medial parietal cortex in patients with treatment-resistant and ultratreatment-resistant schizophrenia
Kazutoshi Kitajima, Shunsuke Tamura, Daiki Sasabayashi, et al.
Molecular Psychiatry
|
September 29, 2021
Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of <sup>1</sup>H-magnetic resonance spectroscopy studies
Tomomi Nakahara, Sakiko Tsugawa, Yoshihiro Noda, et al.
Molecular Psychiatry
|
April 21, 2022
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment
Masataka Wada, Yoshihiro Noda, Yusuke Iwata, et al.
Iscience
|
August 5, 2025
ARID1A mutation drives gastric tumorigenesis via activating type 2 immune dominant microenvironment
Junya Arai, Yoku Hayakawa, Nobumi Suzuki, et al.
Schizophrenia Bulletin
|
November 26, 2023
Disease Progression Patterns of Brain Morphology in Schizophrenia: More Progressed Stages in Treatment Resistance
Daichi Sone, Alexandra Young, Shunichiro Shinagawa, et al.
Page
of 12